COVID-19 vaccination: invitations being sent to risk groups From 27 August 2024 on, the first people will receive an invitation for COVID-19 vaccination. RIVM will send the invitations to people aged 60 years and older.
New COVID-19 vaccination round for risk groups this autumn The new COVID-19 vaccination round will start on 16 September 2024. For people who are at higher risk, the COVID-19 vaccination offers more effective protection against hospital admission or death due to COVID-19.
Metals from Essure sterilisation coils unlikely to be harmful to health Essure is an implant used for female sterilisation. Like many other implants, such as hip implants and stents, this implant is made of metal. It is normal for such implants to release metal particles. Essure is a small implant.
New research portal for people with post-COVID Starting today, people with post-COVID can sign up to take part in scientific research. They can register through the national portal at postcovidonderzoek.nl, which is part of the Post-COVID Network Netherlands.
Increase in STI consultations in 2023, gonorrhoea sees largest rise in cases In 2023, more people had themselves tested for a sexually transmitted infection (STI). The total number of consultations at Sexual Health Centres (SHCs) was 172,113. That represents an increase of 4% compared to 2022.
MEBI: risk of serious health complaints from Rebound HRD® inguinal hernia mesh The Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI), which is part of RIVM, has received a report about Rebound HRD® (Hernia Repair Device), an inguinal hernia mesh.
Well-being should be considered from the start when formulating policy during pandemic, health emergency or other crisis Monitoring well-being from the outset and throughout the duration of a pandemic, health emergency or other crisis provides helpful input in making policy choices.
Study on the effectiveness of COVID-19 measures in the Netherlands The measures implemented in the Netherlands during the COVID-19 crisis were effective against the spread of the SARS-CoV-2 virus. This is the outcome of a study conducted by RIVM.
295 reports of suspected side effects of implants in 2023 In 2023, 295 individuals reported one or more suspected side effects of implants to RIVM’s Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI).
Continuing significant increase in young adults with gonorrhoea The number of people in the Netherlands with gonorrhoea is continuing to increase significantly. Diagnosed cases of this sexually transmitted infection increased by 31% in 2023, compared to 2022. These cases involved people who were tested at a sexual health centre operated by the Municipal Public Health Services (GGDs).